University of Florida researchers examine validity of claims data for otological outcomes.
The Dr. Robert and Barbara Crisafi Chair in Pharmaceutical Outcomes and Policy supports research and work to improve patient safety at hospitals throughout the United States.
University of Florida College of Pharmacy researchers found no evidence that children taking atomoxetine were at an increased risk of suicide or suicide attempts despite an FDA warning.
College of Pharmacy researchers will study the impact of policy changes on pharmacy-generated order sets within UF Health's hospitals.
Dr. Winterstein is recognized as an international leader in drug safety and pharmacoepidemiology.
UF researchers are using risk scores to prevent adverse drug events and better manage glucose levels of hospitalized patients.